CASI Pharmaceuticals, Inc.
CASIFDrugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in CASI Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in CASI Pharmaceuticals, Inc.'s (CASIF) pipeline across Phase 2. Its lead program is ENMD-2076 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CASI Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CASI Pharmaceuticals, Inc. (CASIF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CASIF biotech catalysts?→
Add CASIF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CASI Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.